-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

723.O3.6 723. Allogeneic Transplantation: Long-Term Follow up and Disease Recurrence: Long-term Outcomes Including in Bone Marrow Failure and Rare Diseases

Symposia: Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Clinical trials, Adult, AML, Acute Myeloid Malignancies, Bone Marrow Failure Syndromes, Lymphomas, Clinical Research, Health outcomes research, Aplastic Anemia, Genomics, Diseases, Real-world evidence, Biological therapies, Treatment Considerations, Aggressive lymphoma, Registries, Lymphoid Malignancies, Young adult , Survivorship, Myeloid Malignancies, Biological Processes, Study Population, Human, Transplantation (Allogeneic and Autologous)
Sunday, December 8, 2024: 12:00 PM-1:30 PM
Room 11 (San Diego Convention Center)
Moderators:
Michael Scordo, MD, Memorial Sloan Kettering Cancer Center and Mariam T. Nawas, MD, Department of Medicine, Section of Hematology/Oncology, University of Chicago
Disclosures:
No relevant conflicts of interest to declare.
This session consists of abstracts describing long term outcomes of and risk factors for survival after allogeneic hematopoietic cell transplant. Most of this session focuses on outcomes of rarer diseases such as NK/T cell leukemia, T-prolymphocytic leukemia and aplastic anemia.
12:00 PM

Antonio M Risitano, MD, PhD1,2, Dirk-Jan Eikema Sr.3*, Joe Tuffnell4*, Brian Piepenbroek5*, Victoria Potter6*, Flore Sicre De Fontbrune7,8*, Malek Benakli, MD9*, Krzysztof Kalwak Sr.10*, Elena Skorobogatova Sr.11*, Alexey Maschan, MD, DSc12*, Alexander Kulagin, MD, PhD13*, Jean-Hugues Dalle, MD, PHD14, Ashrafsadat Mousavi15*, Ali Al-Ahmari, MD16*, Caroline Besley, MD17*, Mohsen Al Zahrani18*, Henrik Sengeloev19*, Constantijn J.M. Halkes, MD20*, Rawad Suleiman Rihani, MBBS, MD21*, Mahmoud Aljurf22*, Estelle Verburgh, MBChB, M Med Int, FCPSA, PhD23, Jennifer Clay Sr., MD, PhD24*, Carlos Pinho Vaz25*, Khaled Halahleh Sr., MD26*, Sarah Lawson27*, Nour Ben Abdeljelil, MD28*, Marica Laurino, MD29*, Jakob Passweg Sr.30, Emma Nicholson, MD31*, Ben Carpenter, MD32*, Franco Locatelli, MD33, Matthias Stelljes, MD34*, Matjaz Sever, MD, PhD35, Camilla Frieri36,37*, Austin G. Kulasekararaj, MD, MBBS, FRCPath, MRCP38 and Regis Peffault De Latour39,40*

1Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation (EBMT), Leiden, Netherlands
2Hematology and BMT Unit, AORN San Giuseppe Moscati, Avellino, Italy
3EBMT Statistical Unit, Leiden, Netherlands
4EBMT Leiden Study Unit, Leiden, Netherlands
5EBMTClinical Study Unit, Leiden, Netherlands
6Dept. of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom
7Hematology and Transplant Unit, Saint Louis Hospital, APHP, Paris, France
8French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Saint Louis Hospital, Paris, France
9Pierre and Marie Curie Center, Algiers, Algeria
10Fundacja "Na Ratunek Dzieciom z Choroba Nowotworowa", Wroclaw, Dolnoslaskie, Poland
11The Russian Federationn Children's Research Hospital, MOSCOW, Russian Federation
12Dmitriy Rogachev National Medical Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
13RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russian Federation
14Department of Pediatric Hematology and Immunology, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
15Shariati Hospital, Teheran, Iran (Islamic Republic of)
16King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
17Department of Haematology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
18King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
19Rigshospitalet, Copenhagen, Denmark
20Hematology, Leiden University Medical Center, Leiden, Netherlands
21King Hussein Cancer Centre Pediatric BMT Program, Amman, Jordan
22King Faisal Specialist Hospital & Research Centre, Oncology (Section of Adult Haematolgy/BMT) – Riyadh, Saudi Arabia, Riyadh, Saudi Arabia
23University of Cape Town, Cape Town, South Africa
24Yorkshire Blood & Marrow Transplant Program, Leeds, United Kingdom
25Inst. Português de Oncologia do Porto, Porto, Portugal
26King Hussein Cancer Centre Adult BMT Program, AMMAN, Jordan
27Birmingham Children`s Hospital, Birmingham, United Kingdom
28Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia
29UO Ematologia e terapie cellulari, IRCCS Ospedale Policlinico San martino, Genova, Italy
30University Hospital Basel, Basel, Switzerland
31Royal Marsden NHS Foundation Trust, London, United Kingdom
32University College London Hospitals NHS Foundation Trust, London, United Kingdom
33Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children’s Hospital, Catholic University of the Sacred Heart, Rome, Italy
34Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
35UNIVERSITY CLINICAL CENTRE, LJUBLJANA, Slovenia
36Hematology and Transplant Unit, A.O.R.N. S. Giuseppe Moscati, Avellino, Italy
37European Bone Marrow Transplantation society, Severe Aplastic Anemia Working Party, Leiden, Netherlands
38King’s College Hospital-NHS Foundation Trust, NIHR/Wellcome King’s Clinical Research Facility, and King’s College London, London, United Kingdom
39BMT unit, Hôpital Saint-Louis,, Paris, France
40French Référence Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Paris, France

12:15 PM

Stephanie Clugston, MBBS1, Sylvie Chevret2*, Charlotte Jubert, MD3,4*, Anne Sirvent5*, Arthur Sterin6*, Virginie Gandemer7*, Jérôme Cornillon8*, Fanny Rialland Battisti, MD9*, Jean-Hugues Dalle, MD, PHD10, Edouard Forcade, MD, PhD4,11*, Benedicte Bruno4,12*, Catherine Paillard, MD, PHD13*, Cecile Pochon14*, Michael Loschi, MD, PhD15*, Raynier Devillier, MD, PhD16*, Marie-Thérèse Rubio, MD, PhD17*, Jacques-Olivier Bay, MD, PhD18*, Eolia Brissot19, Jerome Larghero20*, Éliane Gluckman21, Gerard Socie1,4,22, Flore Sicre De Fontbrune1,4,22* and Regis Peffault De Latour1,4,22,23*

1Bone Marrow Transplantation (BMT) Unit, Saint Louis Hospital, Assistance Publique — Hôpitaux de Paris (AP-HP), Paris, France
2Biostatistics and Medical Information Department, Saint Louis Hospital, Assistance Publique — Hôpitaux de Paris (AP-HP), Paris, France
3Pediatric BMT Unit, Bordeaux University Hospital, Bordeaux, France
4French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Saint Louis Hospital, Paris, France
5Pediatric BMT Unit, Montpellier, France
6Hématologie, immunologie et oncologie pédiatrique, Hôpitaux Universitaires de Marseille, Marseille, France
7Pediatric BMT Unit, Rennes, France
8Département d'hématologie Clinique et de Thérapie Cellulaire, CHU Saint-Etienne, Saint-Etienne, France
9Pediatric BMT Unit, Nantes University Hospital, Nantes, France
10Pediatric BMT Unit, Robert-Debré, AP-HP, Paris, France
11BMT and Cell Therapy Unit, Bordeaux, France
12Pediatric BMT Unit, Lille, France
13Pediatric BMT Unit, Strasbourg, France
14Department of Hematology, Centre Hospitalier Régional Universitaire (CHRU), Vandoeuvre-les-Nancy, France
15Hematology Department, Nice University Hospital, Nice, France
16Hematology and Transplantation, Institut Paoli-Calmettes, Aix Marseille University, Marseille, France
17BMT Unit, Nancy, France
18BMT Unit, Clermont-Ferrand University Hospital, Clermont-Ferrand, France
19Service d’hématologie et des maladies du sang, Hôpital Saint-Antoine, Paris, France
20Cell Therapy Unit, Saint-Louis Hospital, APHP, Paris, France
21Eurocord, Saint Louis Hospital, AP-HP, Paris, France
22University Paris Diderot, Paris, France
23Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation, Leiden, Netherlands

12:30 PM

Maria Gabarrós-Subirà1*, Helena Pomares2*, Elisa López-Fernández3*, Alberto Hernández-Sánchez4*, Lourdes Hermosín, PhD5*, Gonzalo Carreño, PhD6*, Ivan Martin Castillo7*, Juan Dominguez Garcia, MD8*, Marta Santiago, MD9*, Maria Jesús Pascual, MD10*, Ana Batlle11*, Maria Julia Montoro, MD, PhD12*, Blanca Ferrer Lores, MD7*, Rosa Ayala, MD6*, José Cervera, MD, PhD9*, Lucia Lopez Corral, MD13*, Francisca Maria Hernandez, MD14*, Francesc Bosch, MD, PhD15, Montserrat Arnan, MD, PhD16*, Carolina Martinez-Laperche, PhD17* and Andres Jerez, MD, PhD18*

1Department of Hematology, University Hospital Vall d’Hebron, Barcelona, España., Barcelona, Spain
2Clinical Hematology Department, ICO-Hospitalet, Hospital Durán i Reynals. IDIBELL, Barcelona., Barcelona, Spain
3Department of Hematology, University Hospital Virgen de las Nieves, Granada, Spain
4Departmente of Hematology, University Hospital Salamanca, Barcelona, Spain
5Department of Hematology, Hospital Jerez de la Frontera, Jerez de la Frontera, Cádiz, Spain
6Hospital Universitario 12 de Octubre, Madrid, Spain
7Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain
8University Hospital MarquéS De Valdecilla - IDIVAL, Santander, Spain
9Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
10Hospital Regional de Málaga, Málaga, Spain
11Department of Hematology, Hospital U. Marqués de Valdecilla, Santander, Spain
12Experimental Hematology. Hematology Department Vall d´Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebrón, BARCELONA, Spain
13Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
14Department of Hematology, Hospital Virgen de las Nieves, Granada, Spain
15Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, University Autonoma of Barcelona (UAB), Barcelona, Spain
16Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), University of Barcelona, Barcelona, Spain
17Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
18Experimental Hematology. Hematology Department Vall d´Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebrón, Barcelona, Spain

12:45 PM

Carlos Jimenez-Vicente1,2*, Maria Queralt Salas1,3*, Jordi Esteve, MD, PhD4,5, Monica Baile Gonzalez6*, Carmen Martin Calvo, MD7*, Itziar Oiartzabal Ormategui, MD8*, Albert Esquirol, MD9*, Felipe Peña, MD10,11*, Sara Fernandez-Luis, MD12*, Inmaculada Heras, MD13*, Ana Pilar Gonzalez-Rodriguez14*, Alberto Lopez Garcia, MD15, Tamara Torrado, MD16*, Adolfo Jesús Sáez Marín, MD17*, Cynthia Acosta Fleitas, PhD18*, Lucia García Mañó19*, Sara Villar, MD20*, Silvia Filafferro21*, Pascual Basalobre22* and Maria Jesús Pascual, MD23*

1Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICHMO, Barcelona, Spain
2Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS),, Barcelona, Spain
3Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain
4Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain
5Hematology Department, Hospital Clínic Barcelona, ICAMS, Barcelona, Spain
6Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
7Hospital Universitario Reina Sofía, Cordoba, Spain
8Hematology Department, Hospital Universitario de Donosti, Donosti, Spain
9Hematology and Hemotherapy Department, Hospital de la Sant Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Universitat Autónoma de Barcelona, Barcelona, Spain
10Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain
11Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain
12Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
13Hematology Division, Hospital Morales Meseguer, Murcia, Spain
14Hospital Universitario Central de Asturias, Oviedo, Spain
15Fundacion Jimenez Diaz University Hospital, Madrid, Spain
16Hospital Universitario de A Coruña, A Coruña, Spain
17Servicio de Hematología, Hospital 12 de Octubre, Madrid, Madrid, Spain
18Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas, ESP
19Hematology Department., Hospital Universitario Son Espases, IdISBa., Palma, Spain
20Hematology and Cell Therapy Department. Clinica Universidad de Navarra. IdiSNA., Pamplona, Spain
21Grupo EspañOl De Trasplante De Progenitores HematopoyéTicos Y Tera, Madrid, ESP
22Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular, Madrid, Spain
23Hematology Department, Hospital Regional Universitario de Málaga, Málaga, Spain

1:00 PM

Zhihui Li1*, Xianxuan Wang1*, Keyan Yang2*, Lei Wang1*, Xiaopei Wen1*, Jingjing Wang1*, Jing Li1*, Yanzhi Song1*, Yongqiang Zhao1*, Qinlong Zheng, MD3* and Tong Wu, MD1

1Department of Bone Marrow Transplantation, Beijing GoBroad Boren Hospital, Beijing, China
2Laboratory of Molecular Diagnostics, Beijing Boren Hospital, Beijing, China
3Laboratory of Molecular Diagnostics, Beijing GoBroad Boren Hospital, Beijing, China

1:15 PM

Joanna Drozd-Sokolowska, MD, PhD1*, Luuk Gras2*, Laurien Baaij3*, Linda Koster3*, Emma Nicholson, MD4*, Peter Dreger5, Tobias Gedde-Dahl, MD6*, Stephan Mielke, MD7, Urpu Salmenniemi, MD8*, Grzegorz Basak9*, Patrice Chevallier, MD, PhD10, Gerald Wulf11*, Johannes Schetelig, MD, MSc12, Jan-Erik Johansson13*, Arnon Nagler, MD14, Stéphanie Nguyen Quoc, MD, PhD15*, Victoria Potter16*, Elisa Sala17*, Anna Bergendahl Sandstedt18*, Yener Koc19*, Robert Zeiser, MD20, Michel van Gelder21*, Wieslaw Wiktor Jedrzejczak, MD, PhD1*, Kavita K Raj, MD, PhD, FRCP, FRCPath22, Olivier Tournilhac23* and Donal P McLornan, MD, PhD24*

1Medical University of Warsaw, University Clinical Centre, Warsaw, Poland
2EBMT, Leiden, Netherlands
3EBMT Leiden Study Unit, Leiden, Netherlands
4Royal Marsden NHS Foundation Trust, London, United Kingdom
5Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
6Oslo University Hospital, Rikshospitalet, Oslo, Norway
7Department of Laboratory Medicine, Cell Therapy and Allogenic Stem Cell Transplantation (CAST), Karolinska Institute & University Hospital, Stockholm, Sweden
8HUCH Comprehensive Cancer Center, Helsinki, Finland, Helsinki, Finland
9Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
10Hematology Department, Nantes University Hospital, Nantes, France
11Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany
12Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Saxony, Germany
13Sahlgrenska University Hospital, Goeteborg, Sweden
14Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Aviv, Israel
15Universite Paris IV, Hopital la Pitié-Salpêtrière, Paris, France
16Dept. of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom
17Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
18University Hospital | Linkoeping, Linkoeping, Sweden
19Medicana International Hospital Istanbul, Istanbul, TUR
20University of Freiburg, Freiburg, Germany
21University Hospital Maastricht, Maastricht, Netherlands
22Department of Haematology, University College London Hospitals NHS Trust, London, United Kingdom
23CHU Estaing, Clermont-Ferrand University Hospital, CLERMONT FERRAND, AURA, France
24Department of Haematology, University College London Hospitals NHS Trust, London, ENG, United Kingdom

*signifies non-member of ASH